Abstract
Background
We sought to determine structure and changes in organisation and bed capacities of certified German chest pain units (CPU) in response to the emergency plan set-up as a response to the SARS-CoV-2 pandemic.
Methods and results
The study was conducted in the form of a standardised telephone interview survey in certified German CPUs. Analyses comprised the overall setting of the CPU, bed capacities, possibilities for ventilation, possible changes in organisation and resources, chest pain patient admittance, overall availability of CPUs and bail-out strategies. The response rate was 91%. Nationwide, CPU bed capacities decreased by 3% in the early phase of COVID-19 pandemic response, exhibiting differences within and between the federal states. Pre-pandemic and pandemic bed capacities stayed below 1 CPU bed per 50,000 inhabitants. 97% of CPUs were affected by internal reorganisation pandemic plans at variable extent. While we observed a decrease of CPU beds within an emergency room (ER) set-up and on intermediate care units (ICU), beds in units being separated from ER and ICU were even increased in numbers.
Conclusions
Certified German CPUs are able to maintain adequate coverage for chest pain patients in COVID-19 pandemic despite structural changes. However, at this time, it appears important to add operating procedures during pandemic outbreaks to the certification criteria of forthcoming guidelines either at the individual CPU level or more centrally steered by the German Cardiac Society or the European Society of Cardiology.
Keywords: Chest pain unit, Germany, Capacity, COVID-19, Pandemic
Introduction
In Germany, new national regulations urged health care providers to increase capacities for SARS-CoV-2-positive individuals. Hospitals were advised to postpone elective operations/interventions to create free capacities for primary care and to double the capacity of 28,000 intensive care unit (ICU) beds [1–3]. Simultaneously, the German Cardiac Society (GCS) addressed the need for maintenance of guideline-adherent clinical practice in cardiac patients despite the emergency plans for COVID-19 patients [4, 5].
At the time of outbreak, German certified chest pain units (CPUs) are building a nationwide network with currently 287 certified units (due date: March 2020), thereby offering a minimum of four fully monitored beds per unit [6–8]. From a survey from 2016, we know that about half of all CPUs are structured as an integral component of the emergency room (ER) and as much as 11% are even located on an ICU, whereas only about 40% are operated as an independent unit or as part of a cardiologic intermediate care (IMC) unit (40%) [9]. Thus, we hypothesized that the increase of ICU bed capacities as well as the set-off of isolation zones in the ERs might interfere with the given CPU structures. The current study aimed to analyse potential changes of CPU set-up and/or bed capacity based on the individual implementations to the COVID-19 emergency plan by each individual hospital housing a certified CPU.
Methods
The study design comprised of a standardised telephone interview survey with a questionnaire focusing on the characterisation of the respective CPU. The interview was carried out either by interviewing the head of the CPU or contacting a CPU hotline where available. Following formal oral consent to participate, the CPU’s medical professionals were assisted to respond to the questionnaire. Data collection included all certified CPUs across Germany. Certified units were identified by the official website of the GCS [1]. Telephone interviews were performed within 15 days. The due date was April 1st 2020. At this time, 67,366 individuals were ‘tested positive’, 732 were reported ‘dead’ and 18,700 cases were reported ‘recovered’ in Germany [10].
Basic CPU characterisation
The CPU characterisation criteria encompassed i) the CPU integration within the hospital facilities, ii) the number of CPU beds per facility, iii) the type of hospital and iv) the capability for mechanical ventilation in the CPU. Thereby, the CPU integration was distinguished into i) CPU as an independent department and/or as an integral part of IMC unit both led by the department of cardiology, ii) CPU as part of the ER or iii) as a part of the ICU. The number of beds was defined as the number of monitored beds fulfilling the CPU criteria according to the GCS. The type of hospital distinguished between i) university hospital, ii) academic teaching hospital and iii) other health facilities provider such as primary care in a community hospital.
COVID-19 emergency plan CPU reorganisation
Reorganizational characterisation criteria comprised changes in organisation, changes in location, changes in bed capacities and changes in ventilator access for invasive and non-invasive ventilation. In case of any changes, the initiator for the changes was asked, thereby distinguishing between administration, CPU head and health department. Additionally, it was evaluated if the individual CPU is still capable to admit patients. This included evaluation of overall availability, possible bail-out strategies and handling of chest pain patients suggestive for SARS-CoV-2 infection. For the latter, due to possible coincidence and co-dependency of patients presenting with fever, respiratory syndromes and chest pain, we specifically asked where these patients were admitted.
Demographic characteristics
Data on population were retrieved from the Registry of the Federal Statistical Office (Statistisches Bundesamt) [11].
Statistics
All data are provided in a descriptive approach without further statistical analysis.
Results
The response rate to the telephone interview was 91%, allowing data collection from 261 certified units by April 1st 2020.
Pre-pandemic structure and capacity
Before activation of the national emergency plans for German hospitals, 44% of CPUs were integral part of the ER, 29% were separate units within the department of cardiology, 18% were part of IMC units, while 9% were part of ICUs. A total of 1.738 CPU beds were provided, which equals one CPU bed per 47.697 inhabitants nationwide with differences between the federal states (Table 1). As referred to the internal structural distribution of CPUs, 684 beds were found in ER settings, 568 beds in separate CPUs, 326 beds within IMC units and 156 beds within ICUs. Regarding the type of hospital, most CPUs were affiliated to academic teaching hospitals (194 CPUs), followed by university hospitals (35 CPUs) and other providers of primary health care (32 CPUs).
Table 1.
Federal State | CPUs total | CPUs included | Population total | Inhabitants/CPU bed pre-pandemic | Inhabitants/CPU bed pandemic | Change (%) |
---|---|---|---|---|---|---|
North Rhine-Westphalia | 66 | 63 | 17.932.651 | 42.901 | 45.864 | − 6.5 |
Bavaria | 54 | 49 | 13.076.721 | 47.379 | 45.723 | + 3.6 |
Baden-Wuerttemberg | 33 | 30 | 11.069.533 | 57.059 | 57.956 | − 1.5 |
Hesse | 24 | 20 | 6.265.809 | 50.126 | 45.404 | + 10.4 |
Lower Saxony | 27 | 24 | 7.982.448 | 45.099 | 52.516 | − 14.1 |
Berlin | 13 | 11 | 3.644.826 | 65.086 | 68.770 | − 5.4 |
Rhineland-Palatinate | 16 | 16 | 4.084.844 | 34.913 | 30.946 | + 12.8 |
Saxony | 15 | 14 | 4.077.937 | 49.731 | 48.547 | + 2.4 |
Schleswig–Holstein | 8 | 7 | 2.896.712 | 61.632 | 57.934 | + 6.4 |
Hamburg | 8 | 7 | 1.841.179 | 51.144 | 70.815 | − 27.8 |
Brandenburg | 8 | 7 | 2.511.917 | 69.775 | 69.775 | − 22.2 |
Mecklenburg-West Pomerania | 5 | 5 | 1.609.675 | 29.809 | 33.535 | − 11.1 |
Thuringia | 4 | 4 | 2.134.393 | 50.819 | 50.819 | ± 0 |
Saxony-Anhalt | 3 | 2 | 2.208.321 | 138.020 | 184.027 | − 25 |
Saarland | 2 | 2 | 990.509 | 30.953 | 30.953 | ± 0 |
Bremen | 2 | 1 | 569.352 | 18.978 | 23.723 | − 20 |
Nationwide | 287 | 261 | 82.896.827 | 47.697 | 49.080 | − 2.8 |
CPU chest pain unit
Changes in structure and capacity during COVID-19 pandemic
Of 261, 97% CPUs stated that they were affected by overall changes due to federal and local pandemic plans to some extent. We observed structural redistribution of CPUs as well as modifications in bed capacities within facilities as a result of preparation for predicted rising numbers of COVID-19 patients. During pandemic, 42% of CPUs were integral part of the ER, 30% were separate units within the department of cardiology, 16% were part of IMC units and 10% were part of ICUs. Eight CPUs (3%) have lost their original CPU structure as functional units. The CPUs now provided 1689 (− 3%) beds in 253 hospitals (− 3%), now offering one bed per 49.080 inhabitants. Of those, 635 (− 7%) were beds in the ER, 610 (+ 7%) in separate CPUs, 288 (− 12%) in IMC units and 156 (± 0%) in ICUs (Fig. 1). While university hospitals increased CPU beds by 4% (+ 10 beds), academic teaching hospitals reduced CPU beds by 3% (− 37 beds) and other providers of primary health care by 9% (− 18 beds) compared to pre-pandemic CPU beds.
Regional distribution of changes in capacity during COVID-19 pandemic
The regional distribution of changes in capacities and, therefore, coverage per inhabitants showed a north–south gradient (Fig. 2). While we observed an increase or no change in CPU coverage in southern states like Bavaria, Rhineland-Palatinate, Hesse, Saxony, Thuringia and Saarland (except for Baden-Wuerttemberg), we saw a decrease in CPU coverage in North Rhine-Westphalia, Lower Saxony, Saxony-Anhalt, Brandenburg, Mecklenburg West-Pomerania (except for Schleswig–Holstein) and in the city states of Berlin, Hamburg and Bremen.
Changes in reorganizational characterisation
25 CPUs (10%) were affected by changes in location, 206 (81%) reported further changes in organisation, 59 (23%) reported changes in bed capacity or equipment, 7 (3%) reported changes in monitoring and 40 (19%) reported that the regional pandemic plans affected processes in non-SARS-CoV-2-infected patients (Fig. 3).
Administrational responsibility for reorganisation during COVID-19 pandemic
The vast majority of hospitals (83%) created a crisis management/taskforce for decisions concerning (re-)organization during pandemic outbreak. In 7%, the hospital or hospital group management was responsible; in a few cases (2%), the medical director was reported responsible. No (re-)organisation was primarily carried out by the health department as the political organ. Of the eight CPUs that closed their admittance, the decision was led by crisis management/taskforce (five CPUs), hospital management (two CPUs) and the medical director (one CPU), offering bail-out strategies with transfer to neighbouring CPUs in four cases (50%).
Admittance of patients with acute chest pain and suspected COVID-19
25% of the hospitals would have admitted chest pain patients with risk for COVID-19 infection to their CPU under isolation conditions, regardless of the internal CPU location. 28% of the hospitals would have admitted patients to the ER under isolation conditions, 19% directly to the ICU, 9% to the IMC unit. 12% would have admitted patients to newly created isolation COVID wards. Others included admissions to isolation containers/tents (< 1%) and other hospitals (2%). 3% (7 in total) of the hospitals were not able to provide standardised monitoring for chest pain patients with suspected SARS-CoV-2 infection.
Capability of mechanical ventilation in CPU
In the pre-pandemic phase, 20% of CPUs reported capability for mechanical ventilation (51 beds). With many hospitals increasing their capacities for mechanical ventilation, in the pandemic phase, one-third of the CPUs were capable of mechanical ventilation (87 beds). We found the highest total increase of 12 beds in the state of North Rhine-Westphalia.
Discussion
Cardiovascular disease patients are at particularly high risk by COVID-19, either directly due to frailty, susceptibility, SARS-CoV-2-related myocardial injury and medication or indirectly because of negative implications resulting from medical system changes [12–15]. The latter may bear the risk of postponing possibly life-saving procedures or vice versa to produce additional patients with acute coronary syndromes and late referral, additionally stressed by reduced access to medical care because of fear for contagion [16]. Resulting from the pandemic outbreak of the novel SARS-CoV-2, the caregivers worldwide pass through a process of reorganisation and restructuration trying to maintain adequate coverage for chest pain patients. Due to limited resources especially in regional hospitals, but also due to limited medical personnel due to infection or quarantine, given diagnostic and even therapeutic standard operating procedures (SOPs) had to be adapted and/or reorganised leading to potential shortening of diagnostic protocols as well as pre- and in-hospital delays [16–18]. As such, German CPUs as part of the German emergency structure were facing a new and unknown situation with no former experience or planned coping strategies. Very early in this process, the GCS took position and addressed the need to maintain infrastructure for handling patients with acute cardiac symptoms [4, 5, 19].
In contrast to 2016 findings, where the nationwide German CPU network—including 230 certified CPUs at this time—provided a mean of 1 CPU bed per 65.000 inhabitants, we found a pre-pandemic versus pandemic CPU bed capacity of 1 CPU bed per 47.700 inhabitants versus 1 CPU bed per 49.000 inhabitants, respectively [9]. While university hospitals were able to increase the total CPU beds, academic teaching hospitals and other health care providers had to reduce CPU beds. Nonetheless, the type of facility did not automatically predict structural resources. As a consequence of restructuration of the first hospital medical encounter location, e.g. enlargement of ER bed capacities or creation of alternative pathways for infectious patients, we saw a relocation of CPU beds out of the ER into separate wards. In some individual cases, this led to a total lack of standardised monitoring. Interestingly, we observed no reduction in CPU beds when being located next ICU beds. This may be due to a massive increase in overall ICU bed capacity or by the low admittance of ICU COVID-19 patients so far and thus may change in times with higher patient volume [20]. Some IMC unit beds may have been upgraded to ICU beds, which may explain at least in part the decrease in CPU beds in IMC units. The observed expanded capacity of mechanical ventilation could be explained as possible preparation for upgrading CPUs in case of rededication to a ventilation ward. We primarily hypothesised that the burden of infection cases per federal state will be reflected in the number of CPU beds per inhabitants. Nevertheless, the observed north–south gradient could neither be explained by the number of infection cases nor by population demographics. With the growing need in ICU beds for COVID-19 patients, we see a possible competition for the 25 CPUs integrated into ICUs, as relocations of beds may become necessary in a short time frame. Reorganisation also bears implications on CPU-specific SOPs. As to the pandemic-adapted plans, about one-fourth of patients presenting with acute chest pain and suspected SARS-CoV-2 infection would have been admitted to pre-existing separate CPUs, where existing SOPs are established and trained. With the restructuration of first hospital medical encounter location and ERs being the place to go for many patients, one-third of the patients would have been admitted to the ER, where CPU processes were implemented, although dedicated CPUs are likely to provide certain superiority with respect to diagnostics and treatment [21].
So far and with all necessary methodical caution, we see a comparably low fatality rate of 1.2% across Germany (due date: April 1th 2020) [22]. We do not anticipate that maintaining high CPU capacities directly affected this rate. However, the lower rate of patients with acute chest pain being admitted and, therefore, treated raises deep concerns towards an evolving substantial increase in early and late infarct-related morbidity and mortality. As this phenomenon is partly explained by system-related factors such as increased critical time intervals or reduced diagnostics, offering enough capacity for cardiac patients at risk will still contribute to reduce collateral fatality rates [16, 23, 24]. Further studies should be performed in the transition and inter-pandemic phase to elucidate COVID-19-associated cardiovascular morbidity and mortality as well as COVID-19-associated morbidity and mortality of non-COVID-19 patients due to structural changes in hospitals and possible delays in first medical contact and emergency medical services. To maintain a high-standard care for cardiovascular patients and especially those with acute ischemia or critical cardiac condition, development of inter- and intra-hospital clinical guidelines on managing acute cardiovascular diseases to support medical care providers during COVID-19 pandemic is highly recommended [18].
Study limitations
Only certified CPUs were included in the study; of those 9% were not reached or refused to take part in the survey. The analysis represents a descriptive observational study without further statistical exploration. The fact that the structured telephone interview was conducted from March 18th to April 1st 2020 bears the risk of bias as we were faced with a highly dynamic situation even within those 15 days and a change of strategy may have been evolved in some hospitals even within this short period of time. However, the order of phone calls was performed by the date of initial certification rather than by location so that the bias is thought to be stretched throughout all regions/federal states. Federal state-specific percentual changes are dependent on the total amount of CPUs reached within the state and should, therefore, viewed with care.
Conclusion
Germany has a strong and tight network of CPUs. With the present survey, we can demonstrate that the CPU bed capacity was held constant despite all reorganisation pressure during the COVID-19 pandemic allowing us to maintain adequate coverage for all chest pain patients. CPUs organised in a separate setting within the department of cardiology seems to be in favour. Providing uniform, central and binding guidelines on managing chest pain patients in SARS-CoV-2-infected and non-infected patients to unify care may be profitable, at least each CPU should be advised to develop corresponding clinical SOPs. Such system may be transferred to a European level, which has recently been put into action [25, 26]. To implement obligatory partaking in central data collection to ensure nationwide quality control could bear further benefit.
Acknowledgements
Open Access funding provided by Projekt DEAL. We are indebted to all participating CPUs taking part in our survey even in the current crisis with limited time; additionally, we thank the GCS, especially its CPU chapter, for their participation and critical review; Thomas Münzel is a PI of the German Center for Cardiovascular Research (DZHK).
Funding
Not applicable.
Availability of data and material
The data underlying this article will be shared anonymised on reasonable request to the corresponding author.
Compliance with ethical standards
Conflict of interest
The authors declare no conflict of interest.
Footnotes
Thomas Münzel and Frank Breuckmann will be considered as joint senior authors.
References
- 1.Bedford J, Enria D, Giesecke J, et al. COVID-19: towards controlling of a pandemic. Lancet. 2020;395(10229):1015–1018. doi: 10.1016/S0140-6736(20)30673-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.World Health Organization (2020) Coronavirus disease 2019 (COVID-19) Situation Report—63. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200323-sitrep-63-covid-19.pdf?sfvrsn=b617302d_4. Accessed 12 Apr 2020
- 3.Spahn J (2020) Brief des Bundesgesundheitsministers an die Geschäftsführerinnen und Geschäftsführer der Krankenhäuser. https://www.bundesgesundheitsministerium.de/coronavirus/chronik-coronavirus.html. Accessed 09 Apr 2020
- 4.German Cardiac Society (2020) DGK-Stellungnahme zur Notfallversorgung von Patienten mit akuten Herzerkrankungen während der Corona-Pandemie. https://dgk.org/daten/versorgung-herzpatienten-corona-pm.pdf. Accessed 09 Apr 2020
- 5.German Cardiac Society (2020) Lebensbedrohliche Herzerkrankungen nicht ignorieren—Notfallversorgung ist gewährleistet!. https://dgk.org/daten/schreiben_herzmedizin_an_mdb_karliczek.pdf. Accessed 12 Apr 2020
- 6.German Cardiac Society (2017) Certification as a chest pain unit. https://cpu-international.dgk.org. Accessed 01 Apr 2020
- 7.Post F, Gori T, Giannitsis E, et al. Criteria of the German Society of Cardiology for the establishment of chest pain units: update 2014. Clin Res Cardiol. 2014;104(11):918–928. doi: 10.1007/s00392-015-0888-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Breuckmann F, Rassaf T, Hochadel M, et al. German chest pain unit registry: data review after the first decade of certification. Herz. 2020 doi: 10.1007/s00059-020-04912-4. [DOI] [PubMed] [Google Scholar]
- 9.Varnavas V, Rassaf T, Breuckmann F. Nationwide but still inhomogeneous distribution of certified chest pain units across Germany: Need to strengthen rural regions. Herz. 2018;43(1):78–86. doi: 10.1007/s00059-016-4527-0. [DOI] [PubMed] [Google Scholar]
- 10.Robert-Koch-Institut (2020) Täglicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19) 01.04.2020—Aktualisierter Stand für Deutschland. https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/2020-04-01-de.pdf?__blob=publicationFile. Accessed 09 Apr 2020
- 11.Statistisches Bundesamt (2019) Fläche und Bevölkerung nach Ländern. https://www.statistikportal.de/de/bevoelkerung/flaeche-und-bevoelkerung. Accessed 09 Apr 2020
- 12.Xiong TY, Redwood S, Prendergast B, et al. Coronaviruses and the cardiovascular system: acute and long-term implications. Eur Heart J. 2020 doi: 10.1093/eurheartj/ehaa231. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Madjid M, Safavi-Naeini P, Solomon SD, et al. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020 doi: 10.1001/jamacardio.2020.1286. [DOI] [PubMed] [Google Scholar]
- 14.Li G, Li H, Lu J. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity. Clin Res Cardiol. 2020 doi: 10.1007/s00392-020-01653-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–538. doi: 10.1007/s00392-020-01626-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gori T, Lelieveld J, Münzel T. Perspective: cardiovascular disease and the Covid-19 pandemic. Basic Res Cardiol. 2020;115(3):32. doi: 10.1007/s00395-020-0792-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Szerlip M, Anwaruddin S, Aronow HD, et al. Considerations for cardiac catheterization laboratory procedures during the COVID-19 pandemic perspectives from the society for cardiovascular angiography and interventions emerging leader mentorship (SCAI ELM) members and graduates. Catheter Cardiovasc Interv. 2020 doi: 10.1002/ccd.28887. [DOI] [PubMed] [Google Scholar]
- 18.Mahmud E, Dauerman HL, Welt FG, et al. Management of acute myocardial infarction during the COVID-19 pandemic. J Am Coll Cardiol. 2020 doi: 10.1016/j.jacc.2020.04.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Zeiher A (2020) In Sorge um unsere Patienten: der Wunsch nach einem Pragmatismus mit Plan! https://dgk.org/daten/pers.statement-amz.pdf. Accessed 08 Apr 2020
- 20.Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (2020) DIVI Intensivregister. https://www.intensivregister.de/#/intensivregister. Accessed 01 Apr 2020
- 21.Münzel T, Heusch G. Chest pain unit network in germany: its effect on patients with acute coronary syndromes. J Am Coll Cardiol. 2017;69(19):2459–2460. doi: 10.1016/j.jacc.2017.03.562. [DOI] [PubMed] [Google Scholar]
- 22.Stafford N. Covid-19: Why Germany's case fatality rate seems so low. BMJ. 2020;369:m1395. doi: 10.1136/bmj.m1395. [DOI] [PubMed] [Google Scholar]
- 23.Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, health care workers, and health systems during the coronavirus disease 2019 (COVID-19) pandemic. J Am Coll Cardiol. 2020 doi: 10.1016/j.jacc.2020.03.031. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Metzler B, Siostrzonek P, Binder RK, et al. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020 doi: 10.1093/eurheartj/ehaa314. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Claeys MJ, Ahrens I, Sinnaeve P, et al. Editor's choice-the organization of chest pain units: position statement of the acute cardiovascular care association. Eur Heart J Acute Cardiovasc Care. 2017;6(3):203–211. doi: 10.1177/2048872617695236. [DOI] [PubMed] [Google Scholar]
- 26.Stepinska J, Lettino M, Ahrens I, et al. Diagnosis and risk stratification of chest pain patients in the emergency department: focus on acute coronary syndromes. A position paper of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2020;9(1):76–89. doi: 10.1177/2048872619885346. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data underlying this article will be shared anonymised on reasonable request to the corresponding author.